Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page's content/metadata.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, signaling a minor update to the page's metadata.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA bibliographic note citing Sindher et al. on the management of gastrointestinal symptoms during oral immunotherapy was added, including PubMed attribution. The revision history was updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision metadata updated from v3.6.0 to v3.6.2, indicating a minor patch-level update. The change does not affect displayed content or functionality.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page adds recruitment-status text and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the Intervention/Treatment label and the revision/version from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check69 days agoChange DetectedThe page revision history shows a new revision entry v3.5.5 added and the previous v3.5.4 removed, signaling an update to the page's documents or metadata.SummaryDifference0.0%

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.